Advertisement
UK markets open in 6 hours 29 minutes
  • NIKKEI 225

    38,103.40
    +551.24 (+1.47%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • CRUDE OIL

    83.44
    +0.08 (+0.10%)
     
  • GOLD FUTURES

    2,336.10
    -6.00 (-0.26%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • Bitcoin GBP

    53,401.19
    -206.07 (-0.38%)
     
  • CMC Crypto 200

    1,432.85
    +18.09 (+1.28%)
     
  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     
  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     

Bausch Health (BHC) Catches Eye: Stock Jumps 6.2%

Bausch Health Companies Inc. BHC was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $20.52–$24.49 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Bausch Health currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Bausch Health Cos Inc. Price

Bausch Health Cos Inc. Price
Bausch Health Cos Inc. Price

Bausch Health Cos Inc. price | Bausch Health Cos Inc. Quote

ADVERTISEMENT

Another stock worth considering in the Medical - Generic Drugs industry is Adamas Pharmaceuticals, Inc. ADMS which carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is BHC going up? Or down? Predict to see what others think:Up or Down

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Adamas Pharmaceuticals, Inc. (ADMS) : Free Stock Analysis Report
 
Bausch Health Cos Inc. (BHC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research